Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GDOC vs PHSYX overlap: 54% of top holdings shared

Bottom line

How much do GDOC and PHSYX overlap?

54% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 55.1% of GDOC's assets and 49.4% of PHSYX's. They share a meaningful core but differ in the rest of the portfolio.

PHSYX holds far more positions (115 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

GDOCPHSYX
Weight overlap (top 25)54%
Shared holdings11
Weight in shared holdings55.1%49.4%
Total positions42115
Expense ratio0.75%0.79%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings GDOC and PHSYX have in common

Holding% of GDOC% of PHSYXOverlap
Eli Lilly & Company LLY13.28%13.15%13.15%
Johnson & Johnson JNJ8.07%8.46%8.07%
Merck & Company Inc MRK5.94%4.88%4.88%
Astrazeneca Plc AZN4.84%4.67%4.67%
Thermo Fisher Scientific Inc TMO4.52%4.50%4.50%
Intuitive Surgical Inc ISRG3.90%4.04%3.90%
Boston Scientific Corp BSX3.78%1.80%1.80%
Hoya Corp 77413.53%1.52%1.52%
Edwards Lifesciences Corp EW2.98%2.80%2.80%
Dexcom Inc DXCM2.79%1.64%1.64%
Vertex Pharmaceuticals Inc VRTX1.48%1.97%1.48%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GDOC

  1. Guardant Health Inc — 5.34%
  2. Argenx Se — 4.07%
  3. Lonza Group Ag — 2.80%
  4. Agilent Technologies Inc — 2.77%
  5. Roivant Sciences Ltd — 2.39%
  6. Cencora Inc — 2.34%
  7. Apogee Therapeutics Inc — 1.97%
  8. Royalty Pharma Plc — 1.77%
  9. Penumbra Inc — 1.61%
  10. Mettler-toledo International Inc — 1.59%
  11. Goldman Sachs Trust — 1.43%
  12. Cytokinetics Inc — 1.40%
  13. Ionis Pharmaceuticals Inc — 1.37%
  14. Xenon Pharmaceuticals Inc — 1.35%

Only in PHSYX

  1. UnitedHealth Group, Inc. — 6.93%
  2. AbbVie, Inc. — 6.05%
  3. Novartis AG — 5.13%
  4. Sanofi SA — 3.23%
  5. Roche Holding AG — 2.79%
  6. CVS Health Corp. — 2.74%
  7. Gilead Sciences, Inc. — 2.63%
  8. McKesson Corp. — 2.14%
  9. Cardinal Health, Inc. — 2.12%
  10. Novo Nordisk A/S — 1.90%
  11. Bristol-Myers Squibb Co. — 1.75%
  12. Putnam Short Term Investment Fund — 1.35%
  13. HCA Healthcare, Inc. — 1.18%
  14. Amgen, Inc. — 1.11%

Asset mix

Asset typeGDOCPHSYX
Stocks98.5%98.2%
Cash & short-term funds1.4%0.6%
Other—1.4%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryGDOCPHSYX
US76.3%76.2%
CH3.9%7.9%
GB6.6%6.4%
NL4.1%1.2%
JP3.5%2.4%
FR0.6%3.2%
BM2.4%—
DK—2.4%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do GDOC and PHSYX overlap?
About 54% by weight. 11 securities appear in both funds' top 25 holdings; they make up 55.1% of GDOC's assets and 49.4% of PHSYX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GDOC and PHSYX have in common?
The largest shared holdings are Eli Lilly & Company, Johnson & Johnson, Merck & Company Inc, Astrazeneca Plc, Thermo Fisher Scientific Inc.
Should I own both GDOC and PHSYX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GDOC or PHSYX?
PHSYX is broader, with 115 positions versus 42 for GDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.